Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 22333176)

1.

[A comparison and significance of plasma riboflavin levels in patients with esophageal squamous cell carcinoma versus Linzhou healthy migrants in Changzhi of Shanxi].

Ji AF, Wei W, Wang JS, Wei ZB, Lian CH, Yang JZ, Zhao L, Ma L, Ma L, Qin XQ, He XF, Wang LD.

Zhonghua Nei Ke Za Zhi. 2011 Dec;50(12):1048-50. Chinese.

PMID:
22333176
2.

[The relationship between C20orf54 gene rs3746804 position single nucleotide polymorphism and susceptibility to esophageal squamous cell carcinoma].

Ji AF, Wei W, Yang JZ, Wang JS, Zhao L, Wei ZB, Lian CH, Ma L, Ma L, Wang HL, Qin XQ, Wang LD.

Zhonghua Nei Ke Za Zhi. 2012 Dec;51(12):982-6. Chinese.

PMID:
23327963
3.

Association of the plasma riboflavin levels and riboflavin transporter (C20orf54) gene statuses in Kazak esophageal squamous cell carcinoma patients.

Ainiwaer J, Tuerhong A, Hasim A, Chengsong D, Liwei Z, Sheyhidin I.

Mol Biol Rep. 2013 May;40(5):3769-75. doi: 10.1007/s11033-012-2453-7. Epub 2012 Dec 30.

PMID:
23275236
4.

Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.

Dong J, Zeng BH, Xu LH, Wang JY, Li MZ, Zeng MS, Liu WL.

J Transl Med. 2010 Sep 3;8:81. doi: 10.1186/1479-5876-8-81.

5.
6.

Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma.

Wang JY, Zheng YZ, Yang J, Lin YH, Dai SQ, Zhang G, Liu WL.

BMC Cancer. 2012 Aug 23;12:365. doi: 10.1186/1471-2407-12-365.

7.

Clinical significance of serum expression of GROβ in esophageal squamous cell carcinoma.

Dong QM, Zhang JQ, Li Q, Bracher JC, Hendricks DT, Zhao XH.

World J Gastroenterol. 2011 Jun 7;17(21):2658-62. doi: 10.3748/wjg.v17.i21.2658.

8.

Relevance of serum estradiol and estrogen receptor beta expression from a high-incidence area for esophageal squamous cell carcinoma in China.

Wang QM, Qi YJ, Jiang Q, Ma YF, Wang LD.

Med Oncol. 2011 Mar;28(1):188-93. doi: 10.1007/s12032-010-9457-8. Epub 2010 Mar 2.

PMID:
20195802
9.

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.

Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, Nagata H, Kosuga T, Iitaka D, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Otsuji E.

Br J Cancer. 2011 Jun 28;105(1):104-11. doi: 10.1038/bjc.2011.198. Epub 2011 Jun 14.

10.
11.

Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.

Lin A, Zhang X, Zhou WJ, Ruan YY, Xu DP, Wang Q, Yan WH.

Int J Cancer. 2011 Sep 15;129(6):1382-90. doi: 10.1002/ijc.25807. Epub 2011 Feb 26.

PMID:
21128238
12.

An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.

Yang YF, Li H, Xu XQ, Diao YT, Fang XQ, Wang Y, Zhao DL, Wu K, Li HQ.

Dis Esophagus. 2008;21(5):395-401. doi: 10.1111/j.1442-2050.2007.00789.x.

PMID:
19125792
13.

Effect of riboflavin-fortified salt nutrition intervention on esophageal squamous cell carcinoma in a high incidence area, China.

He Y, Ye L, Shan B, Song G, Meng F, Wang S.

Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):619-22.

14.

[Serum sCD44v6 and sE-cadherin levels in patients with esophageal squamous cell carcinoma].

He Y, Zhang J, Wang SK, Huang WB, Chen XG, He BS, Zhao YC, Wang JS.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012 May;41(3):305-9. Chinese.

PMID:
22723166
15.
16.

Functional SNPs in human C20orf54 gene influence susceptibility to esophageal squamous cell carcinoma.

Ji A, Wang J, Yang J, Wei Z, Lian C, Ma L, Ma L, Chen J, Qin X, Wang Ld, Wei W.

Asian Pac J Cancer Prev. 2011;12(12):3207-12.

17.

Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.

Xu J, Chen Y, Zhang R, Song Y, Cao J, Bi N, Wang J, He J, Bai J, Dong L, Wang L, Zhan Q, Abliz Z.

Mol Cell Proteomics. 2013 May;12(5):1306-18. doi: 10.1074/mcp.M112.022830. Epub 2013 Feb 8.

18.

Serum markers as predictors of esophageal squamous dysplasia and early cancer.

Chen W, Abnet CC, Wei WQ, Roth MJ, Lu N, Taylor PR, Pan QJ, Luo XM, Dawsey SM, Qiao YL.

Anticancer Res. 2004 Sep-Oct;24(5B):3245-9.

19.

Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.

Łukaszewicz-Zajac M, Mroczko B, Kozłowski M, Nikliński J, Laudański J, Szmitkowski M.

Pol Arch Med Wewn. 2009 Sep;119(9):558-63.

20.

New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma.

Xu SY, Liu Z, Ma WJ, Sheyhidin I, Zheng ST, Lu XM.

Biomarkers. 2009 Aug;14(5):340-6. doi: 10.1080/13547500902903055.

PMID:
19552569
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk